• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    12.06 Down 0.05(0.41%) Jul 31, 4:00PM EDT
    |After Hours : 12.06 0.00 (0.00%) Jul 31, 7:49PM EDT
    Add to Portfolio
    Prev Close:12.11
    Open:12.13
    Bid:12.06 x 300
    Ask:12.50 x 400
    1y Target Est:14.64
    Beta:0.76
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:11.87 - 12.33
    52wk Range:3.92 - 13.12
    Volume:2,694,516
    Avg Vol (3m):3,512,900
    Market Cap:3.23B
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 0.41%3.23B
    MRKUp 0.75%166.57B
    NVSUp 0.55%250.57B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):98.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.41
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback